HOME >> MEDICINE >> NEWS
Widely used treatment for head injuries found to be harmful

This release is also available in German.

The use of anti-inflammatory drugs to treat patients with severe head injuries--common practice worldwide for the past 30 years--is actually dangerous and associated with around a 20% increase in death within two weeks of hospital admission, conclude authors of an international study in this week's issue of THE LANCET.

Around 3 million people worldwide die of trauma every year, many after arrival at hospital. Findings of a 1997 systematic review suggested that these drugs might reduce the risk of death by a few percent; previous individual trials had been too small to provide a clear-cut answer. The CRASH trial (corticosteroid randomisation after significant head injury)--a multicentre international collaboration--aimed to confirm or refute such an effect by recruiting 20,000 patients. In May, 2004, the data monitoring committee disclosed the unmasked results to the steering committee, which stopped recruitment to the trial.

10,008 adults (from 239 hospitals in 49 countries) with head injury were randomly allocated corticosteroids (methylprednisolone) or placebo for 48 hours after admission to a hospital emergency department. Those patients given corticosteroids had a higher death rate within 2 weeks (21% of patients) than those given placebo (18%). The 6-month follow-up data will be presented in a subsequent paper.

Clinical co-ordinator of the study Professor Ian Roberts (London school of Hygiene and Tropical Medicine, UK) comments: "Our early results show that corticosteroids should not be used routinely to treat head injury, whatever the severity. By clearly refuting a mortality benefit from corticosteroids in head injury, the CRASH trial results should protect many thousands of patients from any increased risk of death associated with these drugs... The effect of corticosteroid treatment on disability 6 month
'"/>

Contact: Joe Santangelo
j.santangelo@elsevier.com
1-212-633-3810
Lancet
7-Oct-2004


Page: 1 2

Related medicine news :

1. Widely used breast cancer drug not linked to stroke
2. Widely used anti-nausea drug may interfere with cancer chemotherapy
3. Widely used anti-bacterial inhibits parasites that cause malaria and toxoplasmosis
4. Newest Depression Medications Widely Prescribed For Children
5. Widely Used Therapy May Not Be Effective In Treatment Of Acute Stroke
6. Personality, Thought To Be Stable Over Time, Changes In Healthy People Who Take A Widely Used Anti-Depressant
7. Hormonal treatment improves survival in high-risk prostate cancer patients
8. Chronic pain treatments more effective when taken together, new study shows
9. Brain activity prior to treatment flags vulnerability to antidepressant side effects
10. Cultural and social factors influence prostate cancer treatment
11. Research offers hope of new treatments for liver damage

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/31/2020)... ... ... Covid-19 “PTS” with Mediation & Hypnosis , At this very turbulent time in the ... anxiety, immense stress, and right now are needing serious relief from a constant state of ... are experiencing a great degree of emotional discomfort, be it fear or worrying about their ...
(Date:8/31/2020)... ... August 31, 2020 , ... ... outcomes for patients with advanced heart failure, today announced that the company has ... amount of $555,358 from the National Heart, Lung, and Blood Institute of the ...
(Date:8/28/2020)... ... August 28, 2020 , ... WHAT , Hespiro™ ... patients with respiratory conditions, including COVID-19, while reducing the need for scarce mechanical ... captures exhaled gas and scrubs it free of carbon dioxide in a completely ...
(Date:8/28/2020)... (PRWEB) , ... August 28, 2020 , ... Integrated ... Miami is the first Florida school to deploy its breakthrough Mobile Biodefense Indoor Air ... airborne COVID-19. True North Classical Academy plans to fully reopen equipped with the filtration ...
(Date:8/27/2020)... ... August 27, 2020 , ... Walk-in ... Dermatology team in its Greenvale, New York location. , Loren received her ... Institute. She is certified in chemical peels, microdermabrasion, Hydrafacial MD, dermaplaning, facial lymphatic, ...
Breaking Medicine News(10 mins):
(Date:9/1/2020)... ... September 01, 2020 , ... Mara C. ... Laser Surgery at the University of Rochester Medical Center, in Upstate New York. ... in Boston, with clinical faculty from the Harvard and Yale Departments of Dermatology ...
(Date:8/31/2020)... AVIV, Israel (PRWEB) , ... August 31, 2020 ... ... to specialize in wellness-related technologies, today announced that they have invested $400,000 in ... competition that ran in collaboration with the Global Wellness Institute (GWI). , ...
(Date:8/28/2020)... ... ... Dr. Mark Surrey has been in practice for over 25 years. ... in the Department of OBGYN at UCLA’s David Geffen School of Medicine. , ... and is a Clinical Director of Fellowship Training for UCLA & Cedars Sinai Reproductive ...
Breaking Medicine Technology:
Cached News: